S&P 500   3,959.73 (-0.10%)
DOW   33,686.54 (-0.28%)
QQQ   284.12 (+0.10%)
AAPL   144.03 (+0.97%)
MSFT   246.91 (-0.20%)
META   116.59 (+1.09%)
GOOGL   93.39 (-0.34%)
AMZN   89.50 (-0.94%)
TSLA   180.90 (+4.30%)
NVDA   172.98 (+0.75%)
NIO   12.81 (-4.47%)
BABA   91.98 (-2.33%)
AMD   69.50 (-1.38%)
T   19.20 (+0.42%)
MU   55.33 (+0.24%)
CGC   2.94 (-4.85%)
F   13.21 (+0.69%)
GE   82.17 (-1.75%)
DIS   93.94 (+1.50%)
AMC   5.83 (-3.95%)
PYPL   74.13 (-0.12%)
PFE   51.95 (+0.33%)
NFLX   324.18 (+4.49%)
S&P 500   3,959.73 (-0.10%)
DOW   33,686.54 (-0.28%)
QQQ   284.12 (+0.10%)
AAPL   144.03 (+0.97%)
MSFT   246.91 (-0.20%)
META   116.59 (+1.09%)
GOOGL   93.39 (-0.34%)
AMZN   89.50 (-0.94%)
TSLA   180.90 (+4.30%)
NVDA   172.98 (+0.75%)
NIO   12.81 (-4.47%)
BABA   91.98 (-2.33%)
AMD   69.50 (-1.38%)
T   19.20 (+0.42%)
MU   55.33 (+0.24%)
CGC   2.94 (-4.85%)
F   13.21 (+0.69%)
GE   82.17 (-1.75%)
DIS   93.94 (+1.50%)
AMC   5.83 (-3.95%)
PYPL   74.13 (-0.12%)
PFE   51.95 (+0.33%)
NFLX   324.18 (+4.49%)
S&P 500   3,959.73 (-0.10%)
DOW   33,686.54 (-0.28%)
QQQ   284.12 (+0.10%)
AAPL   144.03 (+0.97%)
MSFT   246.91 (-0.20%)
META   116.59 (+1.09%)
GOOGL   93.39 (-0.34%)
AMZN   89.50 (-0.94%)
TSLA   180.90 (+4.30%)
NVDA   172.98 (+0.75%)
NIO   12.81 (-4.47%)
BABA   91.98 (-2.33%)
AMD   69.50 (-1.38%)
T   19.20 (+0.42%)
MU   55.33 (+0.24%)
CGC   2.94 (-4.85%)
F   13.21 (+0.69%)
GE   82.17 (-1.75%)
DIS   93.94 (+1.50%)
AMC   5.83 (-3.95%)
PYPL   74.13 (-0.12%)
PFE   51.95 (+0.33%)
NFLX   324.18 (+4.49%)
S&P 500   3,959.73 (-0.10%)
DOW   33,686.54 (-0.28%)
QQQ   284.12 (+0.10%)
AAPL   144.03 (+0.97%)
MSFT   246.91 (-0.20%)
META   116.59 (+1.09%)
GOOGL   93.39 (-0.34%)
AMZN   89.50 (-0.94%)
TSLA   180.90 (+4.30%)
NVDA   172.98 (+0.75%)
NIO   12.81 (-4.47%)
BABA   91.98 (-2.33%)
AMD   69.50 (-1.38%)
T   19.20 (+0.42%)
MU   55.33 (+0.24%)
CGC   2.94 (-4.85%)
F   13.21 (+0.69%)
GE   82.17 (-1.75%)
DIS   93.94 (+1.50%)
AMC   5.83 (-3.95%)
PYPL   74.13 (-0.12%)
PFE   51.95 (+0.33%)
NFLX   324.18 (+4.49%)
NASDAQ:KIDS

OrthoPediatrics - KIDS Stock Forecast, Price & News

$40.36
-0.61 (-1.49%)
(As of 12/9/2022 02:43 PM ET)
Add
Compare
Today's Range
$40.36
$41.32
50-Day Range
$37.64
$48.33
52-Week Range
$36.36
$62.25
Volume
993 shs
Average Volume
108,284 shs
Market Capitalization
$923.84 million
P/E Ratio
106.21
Dividend Yield
N/A
Price Target
$54.33

OrthoPediatrics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
33.7% Upside
$54.33 Price Target
Short Interest
Bearish
12.08% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.20
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.69) to ($0.62) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.04 out of 5 stars

Medical Sector

569th out of 1,022 stocks

Surgical & Medical Instruments Industry

61st out of 101 stocks

KIDS stock logo

About OrthoPediatrics (NASDAQ:KIDS) Stock

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

KIDS Stock News Headlines

See More Headlines
Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

KIDS Company Calendar

Last Earnings
10/31/2022
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/01/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:KIDS
Employees
133
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$54.33
High Stock Price Forecast
$62.00
Low Stock Price Forecast
$50.00
Forecasted Upside/Downside
+34.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-16,260,000.00
Pretax Margin
3.48%

Debt

Sales & Book Value

Annual Sales
$98.05 million
Book Value
$11.45 per share

Miscellaneous

Free Float
16,139,000
Market Cap
$923.84 million
Optionable
Not Optionable
Beta
0.77

Key Executives

  • Mr. Mark C. ThrodahlMr. Mark C. Throdahl (Age 71)
    Exec. Chairman
    Comp: $450.17k
  • Mr. David R. Bailey (Age 43)
    Pres, CEO & Director
    Comp: $544.69k
  • Mr. Fred L. HiteMr. Fred L. Hite (Age 54)
    CFO, Principal Financial & Accounting Officer, COO and Director
    Comp: $544.69k
  • Mr. Daniel J. Gerritzen (Age 52)
    VP, Gen. Counsel & Sec.
    Comp: $442.57k
  • Mr. Gregory A. OdleMr. Gregory A. Odle (Age 52)
    Exec. VP of Commercialization
    Comp: $455.6k
  • Mr. Joseph W. Hauser (Age 40)
    Sr. VP and GM of Trauma & Deformity Correction
    Comp: $442.29k
  • Mr. Joel Batts
    Sr. VP of Science & Technology
  • Mr. Mark Karshner
    Sr. VP of International Sales
  • Mr. Paul J. Mraz
    Sr. VP & GM of Scoliosis













KIDS Stock - Frequently Asked Questions

Should I buy or sell OrthoPediatrics stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OrthoPediatrics in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" KIDS shares.
View KIDS analyst ratings
or view top-rated stocks.

What is OrthoPediatrics' stock price forecast for 2023?

4 brokerages have issued twelve-month price objectives for OrthoPediatrics' stock. Their KIDS share price forecasts range from $50.00 to $62.00. On average, they expect the company's share price to reach $54.33 in the next twelve months. This suggests a possible upside of 32.6% from the stock's current price.
View analysts price targets for KIDS
or view top-rated stocks among Wall Street analysts.

How have KIDS shares performed in 2022?

OrthoPediatrics' stock was trading at $59.86 at the beginning of the year. Since then, KIDS shares have decreased by 31.6% and is now trading at $40.97.
View the best growth stocks for 2022 here
.

When is OrthoPediatrics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 1st 2023.
View our KIDS earnings forecast
.

How were OrthoPediatrics' earnings last quarter?

OrthoPediatrics Corp. (NASDAQ:KIDS) released its quarterly earnings data on Monday, October, 31st. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.19) by $0.14. The firm had revenue of $34.95 million for the quarter, compared to analysts' expectations of $36.44 million. OrthoPediatrics had a net margin of 7.90% and a negative trailing twelve-month return on equity of 5.60%.

What guidance has OrthoPediatrics issued on next quarter's earnings?

OrthoPediatrics updated its FY 2022 earnings guidance on Monday, November, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $124.00 million-$125.00 million, compared to the consensus revenue estimate of $128.35 million.

What is Mark Throdahl's approval rating as OrthoPediatrics' CEO?

15 employees have rated OrthoPediatrics Chief Executive Officer Mark Throdahl on Glassdoor.com. Mark Throdahl has an approval rating of 100% among the company's employees. This puts Mark Throdahl in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OrthoPediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrthoPediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Intel (INTC), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Cisco Systems (CSCO), Walt Disney (DIS), Enterprise Products Partners (EPD) and NVIDIA (NVDA).

When did OrthoPediatrics IPO?

(KIDS) raised $52 million in an initial public offering on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

What is OrthoPediatrics' stock symbol?

OrthoPediatrics trades on the NASDAQ under the ticker symbol "KIDS."

Who are OrthoPediatrics' major shareholders?

OrthoPediatrics' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Brown Advisory Inc. (6.85%), Riverbridge Partners LLC (5.22%), BlackRock Inc. (4.16%), Vanguard Group Inc. (3.44%), New York State Common Retirement Fund (1.92%) and State Street Corp (1.57%). Insiders that own company stock include (Reynolds) Marie C Infante, Bernie B Berry III, Bernie B Berry III, Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Gregory A Odle, Harold Ruf, Jennifer N Pritzker, Joseph W Hauser, Mark C Throdahl, Mark C Throdahl, Stephen F Burns and Terry D Schlotterback.
View institutional ownership trends
.

How do I buy shares of OrthoPediatrics?

Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OrthoPediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $40.97.

How much money does OrthoPediatrics make?

OrthoPediatrics (NASDAQ:KIDS) has a market capitalization of $937.89 million and generates $98.05 million in revenue each year. The company earns $-16,260,000.00 in net income (profit) each year or $0.38 on an earnings per share basis.

How many employees does OrthoPediatrics have?

The company employs 133 workers across the globe.

How can I contact OrthoPediatrics?

OrthoPediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The official website for the company is www.orthopediatrics.com. The company can be reached via phone at (574) 268-6379, via email at tbui@theruthgroup.com, or via fax at 574-269-3692.

This page (NASDAQ:KIDS) was last updated on 12/9/2022 by MarketBeat.com Staff